AnaCardio Revenue and Competitors

Solna, se

Location

N/A

Total Funding

Employee Data

  • AnaCardio has 23 Employees.(i)
  • AnaCardio grew their employee count by 44% last year.

AnaCardio's People

NameTitleEmail/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
N/A167%N/AN/A
#2
N/A2713%N/AN/A
#3
N/A12820%N/AN/A
#4
N/A2344%N/AN/A
Add Company

What Is AnaCardio?

AnaCardio AB is a privately held Swedish, clinical stage biopharmaceutical company developing novel drugs to treat heart failure. AnaCardio was founded based on ground-breaking research from Karolinska Institutet showing improved contractility of the heart muscle through a unique and differentiated mechanism. Its lead program AC01 is planned to enter phase 2 clinical development in heart failure patients in 2022. You can find more information about AnaCardio at www.anacardio.com.

keywords:N/A

N/A

Total Funding

23

Number of Employees

N/A

Revenue (est)

44%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$2.4M23-66%N/A
#2
$2M240%N/A
#3
$3M2742%N/A
#4
$2.7M27-4%N/A
#5
$5.4M270%N/A